The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antimalarial Medication Market Research Report 2024

Global Antimalarial Medication Market Research Report 2024

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1426883

No of Pages : 89

Synopsis
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.

Due to the COVID-19 pandemic, the global Antimalarial Medication market size is estimated to be worth US$ 1341.4 million in 2021 and is forecast to a readjusted size of US$ 1820.5 million by 2028 with a CAGR of 4.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Antimalarial Medication market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Antimalarial Medication landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Antimalarial medication are the medicines used to prevent and treat malaria.

This report focuses on Antimalarial Medication volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Antimalarial Medication market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Antimalarial Medication Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Plasmodium Falciparum
  • Plasmodium Malariae
  • Plasmodium Vivax
  • Plasmodium Ovale

Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • E- Commerce
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Glaxosmithkline
  • F. Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
  • Merck
Index

1 Antimalarial Medication Market Overview
1.1 Product Overview and Scope of Antimalarial Medication
1.2 Antimalarial Medication Segment by Type
1.2.1 Global Antimalarial Medication Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Plasmodium Falciparum
1.2.3 Plasmodium Malariae
1.2.4 Plasmodium Vivax
1.2.5 Plasmodium Ovale
1.3 Antimalarial Medication Segment by Application
1.3.1 Global Antimalarial Medication Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E- Commerce
1.3.5 Others
1.4 Global Antimalarial Medication Market Size Estimates and Forecasts
1.4.1 Global Antimalarial Medication Revenue 2017-2028
1.4.2 Global Antimalarial Medication Sales 2017-2028
1.4.3 Antimalarial Medication Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antimalarial Medication Market Competition by Manufacturers
2.1 Global Antimalarial Medication Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antimalarial Medication Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antimalarial Medication Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antimalarial Medication Manufacturing Sites, Area Served, Product Type
2.5 Antimalarial Medication Market Competitive Situation and Trends
2.5.1 Antimalarial Medication Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antimalarial Medication Players Market Share by Revenue
2.5.3 Global Antimalarial Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antimalarial Medication Retrospective Market Scenario by Region
3.1 Global Antimalarial Medication Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antimalarial Medication Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antimalarial Medication Market Facts & Figures by Country
3.3.1 North America Antimalarial Medication Sales by Country
3.3.2 North America Antimalarial Medication Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antimalarial Medication Market Facts & Figures by Country
3.4.1 Europe Antimalarial Medication Sales by Country
3.4.2 Europe Antimalarial Medication Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antimalarial Medication Market Facts & Figures by Region
3.5.1 Asia Pacific Antimalarial Medication Sales by Region
3.5.2 Asia Pacific Antimalarial Medication Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antimalarial Medication Market Facts & Figures by Country
3.6.1 Latin America Antimalarial Medication Sales by Country
3.6.2 Latin America Antimalarial Medication Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antimalarial Medication Market Facts & Figures by Country
3.7.1 Middle East and Africa Antimalarial Medication Sales by Country
3.7.2 Middle East and Africa Antimalarial Medication Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antimalarial Medication Historic Market Analysis by Type
4.1 Global Antimalarial Medication Sales Market Share by Type (2017-2022)
4.2 Global Antimalarial Medication Revenue Market Share by Type (2017-2022)
4.3 Global Antimalarial Medication Price by Type (2017-2022)
5 Global Antimalarial Medication Historic Market Analysis by Application
5.1 Global Antimalarial Medication Sales Market Share by Application (2017-2022)
5.2 Global Antimalarial Medication Revenue Market Share by Application (2017-2022)
5.3 Global Antimalarial Medication Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GlaxoSmithKline Antimalarial Medication Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
6.2.4 F. Hoffmann-La Roche Antimalarial Medication Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis Antimalarial Medication Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Antimalarial Medication Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Merck Antimalarial Medication Product Portfolio
6.6.5 Merck Recent Developments/Updates
7 Antimalarial Medication Manufacturing Cost Analysis
7.1 Antimalarial Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antimalarial Medication
7.4 Antimalarial Medication Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antimalarial Medication Distributors List
8.3 Antimalarial Medication Customers
9 Antimalarial Medication Market Dynamics
9.1 Antimalarial Medication Industry Trends
9.2 Antimalarial Medication Market Drivers
9.3 Antimalarial Medication Market Challenges
9.4 Antimalarial Medication Market Restraints
10 Global Market Forecast
10.1 Antimalarial Medication Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antimalarial Medication by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Antimalarial Medication by Type (2023-2028)
10.2 Antimalarial Medication Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antimalarial Medication by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antimalarial Medication by Application (2023-2028)
10.3 Antimalarial Medication Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antimalarial Medication by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antimalarial Medication by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Antimalarial Medication Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Antimalarial Medication Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Antimalarial Medication Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Antimalarial Medication Market Competitive Situation by Manufacturers in 2021
Table 5. Global Antimalarial Medication Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Antimalarial Medication Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antimalarial Medication Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Antimalarial Medication Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Antimalarial Medication Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Antimalarial Medication Manufacturing Sites and Area Served
Table 11. Manufacturers Antimalarial Medication Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antimalarial Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimalarial Medication as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antimalarial Medication Sales by Region (2017-2022) & (K Units)
Table 16. Global Antimalarial Medication Sales Market Share by Region (2017-2022)
Table 17. Global Antimalarial Medication Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Antimalarial Medication Revenue Market Share by Region (2017-2022)
Table 19. North America Antimalarial Medication Sales by Country (2017-2022) & (K Units)
Table 20. North America Antimalarial Medication Sales Market Share by Country (2017-2022)
Table 21. North America Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Antimalarial Medication Revenue Market Share by Country (2017-2022)
Table 23. Europe Antimalarial Medication Sales by Country (2017-2022) & (K Units)
Table 24. Europe Antimalarial Medication Sales Market Share by Country (2017-2022)
Table 25. Europe Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Antimalarial Medication Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Antimalarial Medication Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Antimalarial Medication Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Antimalarial Medication Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Antimalarial Medication Revenue Market Share by Region (2017-2022)
Table 31. Latin America Antimalarial Medication Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Antimalarial Medication Sales Market Share by Country (2017-2022)
Table 33. Latin America Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Antimalarial Medication Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Antimalarial Medication Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Antimalarial Medication Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Antimalarial Medication Revenue Market Share by Country (2017-2022)
Table 39. Global Antimalarial Medication Sales by Type (2017-2022) & (K Units)
Table 40. Global Antimalarial Medication Sales Market Share by Type (2017-2022)
Table 41. Global Antimalarial Medication Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Antimalarial Medication Revenue Share by Type (2017-2022)
Table 43. Global Antimalarial Medication Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Antimalarial Medication Sales (K Units) by Application (2017-2022)
Table 45. Global Antimalarial Medication Sales Market Share by Application (2017-2022)
Table 46. Global Antimalarial Medication Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antimalarial Medication Revenue Share by Application (2017-2022)
Table 48. Global Antimalarial Medication Price by Application (2017-2022) & (USD/Unit)
Table 49. GlaxoSmithKline Corporation Information
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. GlaxoSmithKline Antimalarial Medication Product
Table 53. GlaxoSmithKline Recent Developments/Updates
Table 54. F. Hoffmann-La Roche Corporation Information
Table 55. F. Hoffmann-La Roche Description and Business Overview
Table 56. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. F. Hoffmann-La Roche Antimalarial Medication Product
Table 58. F. Hoffmann-La Roche Recent Developments/Updates
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Novartis Antimalarial Medication Product
Table 63. Novartis Recent Developments/Updates
Table 64. Pfizer Corporation Information
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Pfizer Antimalarial Medication Product
Table 68. Pfizer Recent Developments/Updates
Table 69. Sun Pharmaceutical Industries Corporation Information
Table 70. Sun Pharmaceutical Industries Description and Business Overview
Table 71. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Sun Pharmaceutical Industries Antimalarial Medication Product
Table 73. Sun Pharmaceutical Industries Recent Developments/Updates
Table 74. Merck Corporation Information
Table 75. Merck Description and Business Overview
Table 76. Merck Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Merck Antimalarial Medication Product
Table 78. Merck Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Antimalarial Medication Distributors List
Table 82. Antimalarial Medication Customers List
Table 83. Antimalarial Medication Market Trends
Table 84. Antimalarial Medication Market Drivers
Table 85. Antimalarial Medication Market Challenges
Table 86. Antimalarial Medication Market Restraints
Table 87. Global Antimalarial Medication Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Antimalarial Medication Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Antimalarial Medication Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 90. Global Antimalarial Medication Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Antimalarial Medication Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Antimalarial Medication Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Antimalarial Medication Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 94. Global Antimalarial Medication Revenue Market Share Forecast by Application (2023-2028)
Table 95. Global Antimalarial Medication Sales Forecast by Region (2023-2028) & (K Units)
Table 96. Global Antimalarial Medication Sales Market Share Forecast by Region (2023-2028)
Table 97. Global Antimalarial Medication Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 98. Global Antimalarial Medication Revenue Market Share Forecast by Region (2023-2028)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antimalarial Medication
Figure 2. Global Antimalarial Medication Market Share by Type in 2021 & 2028
Figure 3. Plasmodium Falciparum Product Picture
Figure 4. Plasmodium Malariae Product Picture
Figure 5. Plasmodium Vivax Product Picture
Figure 6. Plasmodium Ovale Product Picture
Figure 7. Global Antimalarial Medication Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. E- Commerce
Figure 11. Others
Figure 12. Global Antimalarial Medication Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antimalarial Medication Market Size (2017-2028) & (US$ Million)
Figure 14. Global Antimalarial Medication Sales (2017-2028) & (K Units)
Figure 15. Antimalarial Medication Sales Share by Manufacturers in 2021
Figure 16. Global Antimalarial Medication Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Antimalarial Medication Players: Market Share by Revenue in 2021
Figure 18. Antimalarial Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Antimalarial Medication Sales Market Share by Region (2017-2022)
Figure 20. Global Antimalarial Medication Sales Market Share by Region in 2021
Figure 21. Global Antimalarial Medication Revenue Market Share by Region (2017-2022)
Figure 22. Global Antimalarial Medication Revenue Market Share by Region in 2021
Figure 23. U.S. Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Antimalarial Medication by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Antimalarial Medication
Figure 49. Manufacturing Process Analysis of Antimalarial Medication
Figure 50. Antimalarial Medication Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’